FDA approves Regeneron, Sanofi skin cancer immuno-oncology drug

Regeneron headquarters in Tarrytown. Tarrytown-based Regeneron Pharmaceuticals Inc. and French pharma company Sanofi have received U.S. Food and Drug Administration approval for an immuno-oncology drug to treat skin cancer in patients who do not respond to surgery or radiation. Regeneron announced jointly with Paris-based Sanofi that the drug Libtayo […]

Leave a Reply